Patent US4663343A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4663343A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds

Assignee: Warner Lambert Co LLC
•
Filing: 1985-07-19
•
Granted: 1987-05-05
•
Expires: 2005-07-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substituted naphthalenyloxy- or naphthalenylthiooxyamides of trans-1,2-diaminocyclohexanes possess selective kappa opioid receptor site binding activity and are thus useful as analgesic or diuretic agents. Methods of preparing the compounds, pharmaceutical compositions, and a method for their use as analgesic agents are also disclosed.

Inventors

  • 👤 David C. Horwell
  • 👤 David Schofield

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 03:43
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/12; C07D295/135

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 94 words
A compound having structural formula 1 ##STR13## wherein R 1 and R 2 taken together with the nitrogen atom to which they are attached form a pyrrolidinyl ring; and where A is ##STR14## where n is an integer of from one to six; X is oxygen or sulfur; and R 6 and R 7 are independently hydrogen, fluorine, chlorine, bromine, nitro, alkyl of from one to four carbon atoms, alkoxy of from one to four carbon atoms, or acetoxy; or an N-oxide of the pyrrolidinyl nitrogen atom or pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 94 words
A compound having structural formula 1 ##STR13## wherein R 1 and R 2 taken together with the nitrogen atom to which they are attached form a pyrrolidinyl ring; and where A is ##STR14## where n is an integer of from one to six; X is oxygen or sulfur; and R 6 and R 7 are independently hydrogen, fluorine, chlorine, bromine, nitro, alkyl of from one to four carbon atoms, alkoxy of from one to four carbon atoms, or acetoxy; or an N-oxide of the pyrrolidinyl nitrogen atom or pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 11 words
A compound as defined by claim 1 wherein X is oxygen.
Claim 4
Dependent Claim 59 words
A compound as defined by claim 2 wherein A is ##STR15## where n is an integer of from one to six; and R 6 and R 7 are independently hydrogen, fluorine, chlorine, nitro, alkyl of from one to four carbon atoms, alkoxy of from one to four carbon atoms or acetoxy; and the pharmaceutically acceptable acid addition salts thereof.
Claim 5
Dependent Claim 19 words
A compound as defined by claim 3 having the name N-methyl-2-(1-naphthalenyloxy)-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 6
Dependent Claim 19 words
A compound as defined by claim 3 having the name N-methyl-2-(2-naphthalenyloxy)-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 7
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-N-methyl-2-[(2-methyl-1-naphthalenyl)oxy]-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 8
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-2-[(2-chloro-1-naphthalenyl)oxy]-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 9
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-2-[(4-chloro-1-naphthalenyl)oxy]-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 10
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-2-[(2,4-dichloro-1-naphthalenyl)oxy]-N-[2-(1-pyrrolidinyl)cyclohexyl]-N-methylacetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 11
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-2-[(2-acetoxy-1-naphthalenyl)oxy]-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 12
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-2-[(4-methoxy-1-naphthalenyl)oxy]-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 13
Dependent Claim 19 words
A compound as defined by claim 3 having the name trans-N-methyl-2-[(2-nitro-1-naphthalenyl)oxy]-N-[2-(1-pyrrolidinyl)cyclohexyl]acetamide and the pharmaceutically acceptable acid addition salts thereof.
Claim 14
Dependent Claim 30 words
A pharmaceutical composition useful for treating pain in a mammal comprising an analgesically effective amount of a compound in accordance with claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 15
Dependent Claim 37 words
A method of treating pain in a mammal comprising administering to a mammal in need of such treatment an analgesically effective amount of a compound in accordance with claim 1 in combination with a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US4098904A Cited
US4145435A Cited
US4598087A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-04 1990-11-03 1991-05-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-04 1994-11-03 1995-05-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-04 1998-11-03 1999-05-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag